Istradefylline is recommended for morning use: A report of 4 cases

Internal Medicine

Volumn 54, Issue 5, 2015, Pages 509-511

  Matsuura, Keita ^a   Tomimoto, Hidekazu ^b  

^a Suzuka Kaisei Hospital   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

A2A receptor antagonist; Daytime sleepiness; Istradefylline; Parkinson s disease

Indexed keywords

ADENOSINE A2A RECEPTOR ANTAGONIST; DOPA DECARBOXYLASE INHIBITOR; ENTACAPONE; ISTRADEFYLLINE; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE; ZONISAMIDE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; PURINE DERIVATIVE;

AGED; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CASE REPORT; DAYTIME SOMNOLENCE; DRUG DOSE REDUCTION; DRUG EFFECT; EPWORTH SLEEPINESS SCALE; FEMALE; HALLUCINATION; HOEHN AND YAHR SCALE; HUMAN; LIMB TREMOR; MALE; MEDICATION COMPLIANCE; MORNING DOSAGE; MOTOR DYSFUNCTION; PARKINSON DISEASE; QUESTIONNAIRE; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; VERY ELDERLY; ADULT; DRUG EFFECTS; SLEEP;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; PARKINSON DISEASE; PURINES; SLEEP;

EID: 84923668770     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.3522     Document Type: Article

References (6)

1. Mizuno Y, Hasegawa K, Kondo T, Kuno S, Yamamoto M. Clinical efficacy of istradefylline (KW-6002) in Parkinson’s disease: a randomized, controlled study. Mov Disord 25: 1437-1443, 2010.
2. Mizuno Y, Kondo T. Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease. Mov Disord 28: 1138-1141, 2013.
3. Fitzpatrick R, Peto V, Jenkinson C, Greenhall R, Hyman N. Health-related quality of life in Parkinson’s disease: a study of outpatient clinic attenders. Mov Disord 12: 916-922, 1997.
4. Lazarus M, Shen H-Y, Cherasse Y, et al. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 31: 10067-10075, 2011.
5. Saki M, Yamada K, Koshimura E, Sasaki K, Kanda T. In vitro pharmacological profile of the A2A receptor antagonist istradefylline. Naunyn Schmiedebergs Arch Pharmacol 386: 963-972, 2013.
6. Lazarus M, Chen J-F, Urade Y, Huang Z-L. Role of the basal ganglia in the control of sleep and wakefulness. Curr Opin Neurobiol 23: 780-785, 2013.